Mindray's anaesthesia delivery system gets FDA go-ahead
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance to Mindray Medical International's AS3000 anaesthesia delivery system. The Shenzhen, China firm described it as a "next-generation" system which "delivers precision anaesthesia and ventilation assistance with an intuitive design". Mindray estimates that the US anaesthesia delivery systems market will reach $250m this year. The AS3000 can be used in various settings including hospitals, health clinics, outpatient and ambulatory surgery centres. The system was developed by US firm Datascope, which Mindray agreed to buy in March.